We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSIC icon
701
Henry Schein
HSIC
$9.74B
$282K ﹤0.01%
5,151
– –
MUR icon
702
Murphy Oil
MUR
$5.58B
$281K ﹤0.01%
9,038
-41,255
-82% -$1.15M
GIB icon
703
CGI
GIB
$13.9B
$279K ﹤0.01%
+5,115
New +$272K
FSTX
704
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$269K ﹤0.01%
+5,000
New +$297K
CVE icon
705
Cenovus Energy
CVE
$54.6B
$264K ﹤0.01%
28,818
-27,101
-48% -$263K
RL icon
706
Ralph Lauren
RL
$22.2B
$259K ﹤0.01%
+2,498
New +$231K
ASRT
707
DELISTED
Assertio
ASRT
$254K ﹤0.01%
525
-172
-25% -$66.9K
FNV icon
708
Franco-Nevada
FNV
$41.4B
$254K ﹤0.01%
+3,165
New +$254K
VALE icon
709
Vale
VALE
$62.9B
$249K ﹤0.01%
20,335
+6,126
+43% +$65K
EPAM icon
710
EPAM Systems
EPAM
$4.69B
$236K ﹤0.01%
+2,200
New +$218K
SPR
711
DELISTED
Spirit AeroSystems
SPR
$234K ﹤0.01%
+2,682
New +$220K
BBD icon
712
Banco Bradesco
BBD
$38.1B
$230K ﹤0.01%
39,504
+3,510
+10% +$21K
VRN
713
DELISTED
Veren
VRN
$230K ﹤0.01%
30,116
-7,993
-21% -$60.2K
AMG icon
714
Affiliated Managers Group
AMG
$9.46B
$222K ﹤0.01%
+1,080
New +$209K
INFY icon
715
Infosys
INFY
$45B
$219K ﹤0.01%
27,040
-3,840
-12% -$29.2K
QSR icon
716
Restaurant Brands International
QSR
$25.1B
$219K ﹤0.01%
+3,549
New +$228K
ABEV icon
717
Ambev
ABEV
$47.3B
$214K ﹤0.01%
33,130
– –
CBI
718
DELISTED
Chicago Bridge & Iron Nv
CBI
$211K ﹤0.01%
+13,077
New +$213K
AMX icon
719
America Movil
AMX
$78.1B
$209K ﹤0.01%
12,170
– –
EEM icon
720
iShares MSCI Emerging Markets ETF
EEM
$28B
$208K ﹤0.01%
+4,393
New +$203K
VRSN icon
721
VeriSign
VRSN
$25.3B
$208K ﹤0.01%
+1,819
New +$203K
PBCT
722
DELISTED
People's United Financial Inc
PBCT
$208K ﹤0.01%
+11,125
New +$206K
MRSN
723
DELISTED
Mersana Therapeutics
MRSN
$197K ﹤0.01%
+480
New +$209K
PBR icon
724
Petrobras
PBR
$121B
$160K ﹤0.01%
15,535
+1,350
+10% +$13.8K
NAVI icon
725
Navient
NAVI
$774M
$133K ﹤0.01%
10,000
-9,132
-48% -$115K
27 28
29
30 31

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.